Centre International de Développement Pharmaceutique (CIDP) is a private and independent CRO carrying out high performance research and clinical activities for pharmaceutical, medical device, nutrition and cosmetic industries.
We serve our clients both as a service provider upstream through Research and Preclinical activities and downstream through Regulatory affairs, Biostatistics & Data Management and Clinical Research.
The geographical locations of our centres enable the access to a wide panel of patients. This allows us to undertake multi-centric trials with a rapid recruitment process in a secured and adapted environment.
Recognised for its expertise, CIDP forms part of the IBL group.
IBL is ranked among the 16 most dynamic and fast growing companies in Africa according to the World Economic Forum in 2014. Ranked number 1 in the TOP 100 Mauritian companies and number 3 in the Indian Ocean, IBL has recently decided to invest in Life sciences through its subsidiary: IBL Life. Its ambition is to become the essential starting point in this growing sector.
Ethics & Quality
It is of utmost importance that our company maintains the highest possible ethics standards. We want to work responsibly and set an example as being a leading company with the highest possible business ethics. The safety and the wellbeing of our patients remain our priority throughout our clinical studies. We are committed to having a zero tolerance approach towards fraud and corruption.
Our focus on Service Quality is an important part of the CIDP work culture. We have implemented a Group quality management system to ensure that our high standards are followed within all our subsidiaries. We also place emphasis on client data confidentiality and we have implemented measures to ensure data protection.